GIS:FRA
Gilead Sciences, Inc
€152.86
arrow_upward
+1.92%(+2.88) 1D
ኖቬም 11, 10:00:00 ከሰዓት ጂ ኤም ቲ+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€151.34
High
€152.86
Low
€151.34
Mkt. cap
210.52 ቢ
Avg. vol.
196.00
Volume
731.00
52-wk high
€157.14
52-wk low
€100.42
No. of employees
17 ሺ
Open
€151.34
High
€152.86
Low
€151.34
Mkt. cap
210.52 ቢ
Avg. vol.
196.00
Volume
731.00
52-wk high
€157.14
52-wk low
€100.42
No. of employees
17 ሺ
News stories
From web sources and news partners
Yahoo Finance
·
ከ7 ሰዓቶች በፊት
Gilead (GILD) Stock Still Looks Undervalued On Its 205% Run
Yahoo Finance
·
ከ9 ሰዓቶች በፊት
Gilead Sciences (GILD) After Trial Wins And Raised Guidance Looks Fully Valued
Trefis
·
ከ1 ቀን በፊት
Can Gilead’s Cash Keep Growing?
Investing.com
·
ከ1 ቀን በፊት
Gilead at Wolfe Healthcare Conference: anito-cel launch in focus
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences, Inc
CEODaniel O'Day
Employees17 ሺ
Founded22 ጁን 1987
HeadquartersFoster City, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitegilead.com